CPRX vs. TJX

Last updated Jun 9, 2026

CPRX (Catalyst Pharmaceuticals, Inc.) and TJX (The TJX Companies, Inc.) are both stocks. CPRX operates in Biotechnology (Healthcare), while TJX operates in Apparel Retail (Consumer Cyclical). Over the past 10 years, CPRX returned 48.01%/yr vs 16.92%/yr for TJX. At a 0.13 correlation, their price movements are largely independent.

Performance

CPRX vs. TJX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Catalyst Pharmaceuticals, Inc. (CPRX) and The TJX Companies, Inc. (TJX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CPRX achieves a 34.02% return, which is significantly higher than TJX's 4.63% return. Over the past 10 years, CPRX has outperformed TJX with an annualized return of 48.01%, while TJX has yielded a comparatively lower 16.92% annualized return.

CPRX

• 1D: 0.03%
• 1M: 0.42%
• YTD: 34.02%
• 6M: 35.06%
• 1Y: 20.91%
• 3Y*: 39.11%
• 5Y*: 40.76%
• 10Y*: 48.01%

TJX

• 1D: -0.60%
• 1M: 4.51%
• YTD: 4.63%
• 6M: 4.56%
• 1Y: 25.89%
• 3Y*: 27.94%
• 5Y*: 21.45%
• 10Y*: 16.92%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CPRX vs. TJX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CPRX Catalyst Pharmaceuticals, Inc.	34.02%	11.84%	24.15%	-9.62%	174.74%	102.69%	-10.93%	95.31%	-50.90%	272.38%
TJX The TJX Companies, Inc.	4.63%	28.73%	30.56%	19.69%	6.73%	12.83%	12.25%	38.76%	18.94%	3.46%

Correlation

The correlation between CPRX and TJX is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.21
Correlation (5Y) Calculated over the trailing 5-year period	0.25
Correlation (10Y) Calculated over the trailing 10-year period	0.22
Correlation (All Time) Calculated using the full available price history since Nov 9, 2006	0.13

The correlation between CPRX and TJX shifts across timeframes, from 0.07 (1 year) to 0.25 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CPRX : $3.97B TJX : $178.92B
EPS CPRX : $1.74 TJX : $5.15
PE Ratio CPRX : 17.98 TJX : 31.03
PEG Ratio CPRX : 0.32 TJX : 1.96
PS Ratio CPRX : 6.67 TJX : 2.92
PB Ratio CPRX : 3.92 TJX : 4.95
Total Revenue (TTM) CPRX : $596.96M TJX : $61.58B
Gross Profit (TTM) CPRX : $378.23M TJX : $19.36B
EBITDA (TTM) CPRX : $313.50M TJX : $8.31B

Return for Risk

CPRX vs. TJX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CPRX

CPRX Risk / Return Rank: 59
CPRX Sharpe Ratio Rank: 63
CPRX Sortino Ratio Rank: 57
CPRX Omega Ratio Rank: 57
CPRX Calmar Ratio Rank: 59
CPRX Martin Ratio Rank: 57

TJX

TJX Risk / Return Rank: 80
TJX Sharpe Ratio Rank: 82
TJX Sortino Ratio Rank: 80
TJX Omega Ratio Rank: 76
TJX Calmar Ratio Rank: 79
TJX Martin Ratio Rank: 86

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CPRX vs. TJX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and The TJX Companies, Inc. (TJX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CPRX	TJX	Difference
Sharpe ratio: Return per unit of total volatility	0.63	1.46	-0.83
Sortino ratio: Return per unit of downside risk	1.08	2.25	-1.17
Omega ratio: Gain probability vs. loss probability	1.14	1.26	-0.12
Calmar ratio: Return relative to maximum drawdown	0.77	2.39	-1.62
Martin ratio: Return relative to average drawdown	1.40	8.72	-7.32
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CPRX vs. TJX - Sharpe Ratio Comparison

The current CPRX Sharpe Ratio is 0.63, which is lower than the TJX Sharpe Ratio of 1.46. The chart below compares the historical Sharpe Ratios of CPRX and TJX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CPRX	TJX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.63	1.46	-0.83
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.86	0.97	-0.11
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.80	0.65	+0.15
Sharpe Ratio (All Time) Calculated using the full available price history	0.09	0.54	-0.45

Drawdowns

CPRX vs. TJX - Drawdown Comparison

The maximum CPRX drawdown since its inception was -94.25%, which is greater than TJX's maximum drawdown of -64.59%. Use the drawdown chart below to compare losses from any high point for CPRX and TJX.

Drawdown Indicators

	CPRX	TJX	Difference
Max Drawdown Largest peak-to-trough decline	-94.25%	-64.59%	-29.66%
Max Drawdown (1Y) Largest decline over 1 year	-27.29%	-10.89%	-16.40%
Max Drawdown (3Y) Largest decline over 3 years	-27.29%	-11.04%	-16.25%
Max Drawdown (5Y) Largest decline over 5 years	-45.37%	-27.68%	-17.69%
Max Drawdown (10Y) Largest decline over 10 years	-64.87%	-42.55%	-22.32%
Current Drawdown Current decline from peak	-0.16%	-2.86%	+2.70%
Average Drawdown Average peak-to-trough decline	-52.02%	-13.08%	-38.94%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.95%	3.16%	+11.79%

Volatility

CPRX vs. TJX - Volatility Comparison

The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 0.44%, while The TJX Companies, Inc. (TJX) has a volatility of 8.27%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than TJX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CPRX	TJX	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.44%	8.27%	-7.83%
Volatility (6M) Calculated over the trailing 6-month period	23.50%	14.08%	+9.42%
Volatility (1Y) Calculated over the trailing 1-year period	33.58%	17.84%	+15.74%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	47.80%	22.29%	+25.51%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	60.47%	26.05%	+34.42%

Dividends

CPRX vs. TJX - Dividend Comparison

CPRX has not paid dividends to shareholders, while TJX's dividend yield for the trailing twelve months is around 1.10%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CPRX Catalyst Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
TJX The TJX Companies, Inc.	1.10%	1.07%	1.21%	1.38%	1.44%	1.37%	0.34%	1.45%	1.66%	1.57%	1.32%	1.14%

Financials

CPRX vs. TJX - Profitability Comparison

The chart below illustrates the profitability comparison between Catalyst Pharmaceuticals, Inc. and The TJX Companies, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CPRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.

TJX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The TJX Companies, Inc. reported a gross profit of 4.48B and revenue of 14.32B. Therefore, the gross margin over that period was 31.3%.

CPRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.

TJX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The TJX Companies, Inc. reported an operating income of 1.69B and revenue of 14.32B, resulting in an operating margin of 11.8%.

CPRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.

TJX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The TJX Companies, Inc. reported a net income of 1.33B and revenue of 14.32B, resulting in a net margin of 9.3%.

Frequently Asked Questions

Can I hold both CPRX and TJX in my portfolio?

CPRX and TJX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CPRX or TJX?

TJX has higher volatility (8.27%) compared to CPRX (0.44%). In terms of maximum drawdown, CPRX dropped -94.25% vs TJX's -64.59%.

Which has better risk-adjusted returns?

TJX currently has the higher Sharpe Ratio (1.46 vs 0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.